Antivert (Meclizine HCl) - Summary

ANTIVERT SUMMARY

Antivert® (meclizine HCl) is an antihistamine.

Based on a review of this drug by the National Academy of Sciences-National Research Council and/or other information, FDA has classified the indications as follows:

Effective: Management of nausea and vomiting, and dizziness associated with motion sickness.

Possibly Effective: Management of vertigo associated with diseases affecting the vestibular system.

ANTIVERT NEWS HIGHLIGHTS

Published Studies Related to Antivert (Meclizine)

Meclizine for prevention of nausea associated with use of emergency contraceptive pills: a randomized trial. [2000.02]

Central nervous system effects of meclizine and dimenhydrinate: evidence of acute tolerance to antihistamines. [1992.11]

Meclizine in combination with ondansetron for prevention of postoperative nausea and vomiting in a high-risk population. [2007.02]

Physiological and behavioral effects of an antivertigo antihistamine in adults. [1999.06]

more>>

Clinical Trials Related to Antivert (Meclizine)

The Vertigo Study: Comparison Between Convention Therapy and Vestibular Rehabilitation for Benign Paroxysmal Positional Vertigo (BPPV) in Emergency Department (ED) Patients [Enrolling by invitation]

more>>